Skip to main content
Top
Published in: Neuroscience Bulletin 4/2019

01-08-2019 | Schizophrenia | Original Article

Age-Related Reduction in Cortical Thickness in First-Episode Treatment-Naïve Patients with Schizophrenia

Authors: Yin Lin, Mingli Li, Yi Zhou, Wei Deng, Xiaohong Ma, Qiang Wang, Wanjun Guo, Yinfei Li, Lijun Jiang, Xun Hu, Nanyin Zhang, Tao Li

Published in: Neuroscience Bulletin | Issue 4/2019

Login to get access

Abstract

Substantial evidence supports the neurodevelopmental hypothesis of schizophrenia. Meanwhile, progressive neurodegenerative processes have also been reported, leading to the hypothesis that neurodegeneration is a characteristic component in the neuropathology of schizophrenia. However, a major challenge for the neurodegenerative hypothesis is that antipsychotic drugs used by patients have profound impact on brain structures. To clarify this potential confounding factor, we measured the cortical thickness across the whole brain using high-resolution T1-weighted magnetic resonance imaging in 145 first-episode and treatment-naïve patients with schizophrenia and 147 healthy controls. The results showed that, in the patient group, the frontal, temporal, parietal, and cingulate gyri displayed a significant age-related reduction of cortical thickness. In the control group, age-related cortical thickness reduction was mostly located in the frontal, temporal, and cingulate gyri, albeit to a lesser extent. Importantly, relative to healthy controls, patients exhibited a significantly smaller age-related cortical thickness in the anterior cingulate, inferior temporal, and insular gyri in the right hemisphere. These results provide evidence supporting the existence of neurodegenerative processes in schizophrenia and suggest that these processes already occur in the early stage of the illness.
Literature
2.
go back to reference Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987, 44: 660–669.CrossRefPubMed Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987, 44: 660–669.CrossRefPubMed
3.
go back to reference Murray RM, Lewis SW. Is schizophrenia a neurodevelopmental disorder? Br Med J (Clin Res Ed) 1987, 295: 681–682.CrossRef Murray RM, Lewis SW. Is schizophrenia a neurodevelopmental disorder? Br Med J (Clin Res Ed) 1987, 295: 681–682.CrossRef
4.
go back to reference Zhao X, Tian L, Yan J, Yue W, Yan H, Zhang D. Abnormal rich-club organization associated with compromised cognitive function in patients with schizophrenia and their unaffected parents. Neurosci Bull 2017, 33: 445–454.CrossRefPubMedPubMedCentral Zhao X, Tian L, Yan J, Yue W, Yan H, Zhang D. Abnormal rich-club organization associated with compromised cognitive function in patients with schizophrenia and their unaffected parents. Neurosci Bull 2017, 33: 445–454.CrossRefPubMedPubMedCentral
5.
go back to reference Fenton WS, McGlashan TH. Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia. Am J Psychiatry 1994, 151: 351–356.CrossRefPubMed Fenton WS, McGlashan TH. Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia. Am J Psychiatry 1994, 151: 351–356.CrossRefPubMed
6.
go back to reference Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR. Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 1992, 149: 1183–1188.CrossRefPubMed Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR. Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 1992, 149: 1183–1188.CrossRefPubMed
7.
go back to reference Wyatt RJ. Neuroleptics and the natural course of schizophrenia. Schizophr Bull 1991, 17: 325–351.CrossRefPubMed Wyatt RJ. Neuroleptics and the natural course of schizophrenia. Schizophr Bull 1991, 17: 325–351.CrossRefPubMed
8.
go back to reference Cahn W, Hulshoff Pol HE, Lems EB, van Haren NE, Schnack HG, van der Linden JA, et al. Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Arch Gen Psychiatry 2002, 59: 1002–1010.CrossRefPubMed Cahn W, Hulshoff Pol HE, Lems EB, van Haren NE, Schnack HG, van der Linden JA, et al. Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Arch Gen Psychiatry 2002, 59: 1002–1010.CrossRefPubMed
9.
go back to reference DeLisi LE, Tew W, Xie S, Hoff AL, Sakuma M, Kushner M, et al. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings. Biol Psychiatry 1995, 38: 349–360.CrossRefPubMed DeLisi LE, Tew W, Xie S, Hoff AL, Sakuma M, Kushner M, et al. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings. Biol Psychiatry 1995, 38: 349–360.CrossRefPubMed
10.
go back to reference DeLisi LE, Sakuma M, Tew W, Kushner M, Hoff AL, Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res 1997, 74: 129–140.CrossRefPubMed DeLisi LE, Sakuma M, Tew W, Kushner M, Hoff AL, Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res 1997, 74: 129–140.CrossRefPubMed
11.
go back to reference Whitford TJ, Grieve SM, Farrow TF, Gomes L, Brennan J, Harris AW, et al. Progressive grey matter atrophy over the first 2-3 years of illness in first-episode schizophrenia: a tensor-based morphometry study. Neuroimage 2006, 32: 511–519.CrossRefPubMed Whitford TJ, Grieve SM, Farrow TF, Gomes L, Brennan J, Harris AW, et al. Progressive grey matter atrophy over the first 2-3 years of illness in first-episode schizophrenia: a tensor-based morphometry study. Neuroimage 2006, 32: 511–519.CrossRefPubMed
12.
go back to reference Ho BC, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry 2003, 60: 585–594.CrossRefPubMed Ho BC, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry 2003, 60: 585–594.CrossRefPubMed
13.
go back to reference Kasai K, Shenton ME, Salisbury DF, Hirayasu Y, Lee CU, Ciszewski AA, et al. Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia. Am J Psychiatry 2003, 160: 156–164.CrossRefPubMedPubMedCentral Kasai K, Shenton ME, Salisbury DF, Hirayasu Y, Lee CU, Ciszewski AA, et al. Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia. Am J Psychiatry 2003, 160: 156–164.CrossRefPubMedPubMedCentral
14.
go back to reference Mathalon DH, Sullivan EV, Lim KO, Pfefferbaum A. Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry 2001, 58: 148–157.CrossRefPubMed Mathalon DH, Sullivan EV, Lim KO, Pfefferbaum A. Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry 2001, 58: 148–157.CrossRefPubMed
15.
go back to reference Jacobsen LK, Giedd JN, Castellanos FX, Vaituzis AC, Hamburger SD, Kumra S, et al. Progressive reduction of temporal lobe structures in childhood-onset schizophrenia. Am J Psychiatry 1998, 155: 678–685.CrossRefPubMed Jacobsen LK, Giedd JN, Castellanos FX, Vaituzis AC, Hamburger SD, Kumra S, et al. Progressive reduction of temporal lobe structures in childhood-onset schizophrenia. Am J Psychiatry 1998, 155: 678–685.CrossRefPubMed
16.
go back to reference Thompson PM, Vidal C, Giedd JN, Gochman P, Blumenthal J, Nicolson R, et al. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci U S A 2001, 98: 11650–11655.CrossRefPubMedPubMedCentral Thompson PM, Vidal C, Giedd JN, Gochman P, Blumenthal J, Nicolson R, et al. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci U S A 2001, 98: 11650–11655.CrossRefPubMedPubMedCentral
17.
go back to reference Keller A, Castellanos FX, Vaituzis AC, Jeffries NO, Giedd JN, Rapoport JL. Progressive loss of cerebellar volume in childhood-onset schizophrenia. Am J Psychiatry 2003, 160: 128–133.CrossRefPubMed Keller A, Castellanos FX, Vaituzis AC, Jeffries NO, Giedd JN, Rapoport JL. Progressive loss of cerebellar volume in childhood-onset schizophrenia. Am J Psychiatry 2003, 160: 128–133.CrossRefPubMed
18.
go back to reference Sporn AL, Greenstein DK, Gogtay N, Jeffries NO, Lenane M, Gochman P, et al. Progressive brain volume loss during adolescence in childhood-onset schizophrenia. Am J Psychiatry 2003, 160: 2181–2189.CrossRefPubMed Sporn AL, Greenstein DK, Gogtay N, Jeffries NO, Lenane M, Gochman P, et al. Progressive brain volume loss during adolescence in childhood-onset schizophrenia. Am J Psychiatry 2003, 160: 2181–2189.CrossRefPubMed
19.
go back to reference van Haren NE, Schnack HG, Cahn W, van den Heuvel MP, Lepage C, Collins L, et al. Changes in cortical thickness during the course of illness in schizophrenia. Arch Gen Psychiatry 2011, 68: 871–880.CrossRefPubMed van Haren NE, Schnack HG, Cahn W, van den Heuvel MP, Lepage C, Collins L, et al. Changes in cortical thickness during the course of illness in schizophrenia. Arch Gen Psychiatry 2011, 68: 871–880.CrossRefPubMed
20.
go back to reference Xie T, Zhang X, Tang X, Zhang H, Yu M, Gong G, et al. Mapping convergent and divergent cortical thinning patterns in patients with deficit and nondeficit schizophrenia. Schizophr Bull 2019, 45: 211–221.CrossRefPubMed Xie T, Zhang X, Tang X, Zhang H, Yu M, Gong G, et al. Mapping convergent and divergent cortical thinning patterns in patients with deficit and nondeficit schizophrenia. Schizophr Bull 2019, 45: 211–221.CrossRefPubMed
21.
go back to reference Buchy L, Makowski C, Malla A, Joober R, Lepage M. A longitudinal study of cognitive insight and cortical thickness in first-episode psychosis. Schizophr Res 2018, 193: 251–260.CrossRefPubMed Buchy L, Makowski C, Malla A, Joober R, Lepage M. A longitudinal study of cognitive insight and cortical thickness in first-episode psychosis. Schizophr Res 2018, 193: 251–260.CrossRefPubMed
22.
go back to reference Wiegand LC, Warfield SK, Levitt JJ, Hirayasu Y, Salisbury DF, Heckers S, et al. Prefrontal cortical thickness in first-episode psychosis: a magnetic resonance imaging study. Biol Psychiatry 2004, 55: 131–140.CrossRefPubMedPubMedCentral Wiegand LC, Warfield SK, Levitt JJ, Hirayasu Y, Salisbury DF, Heckers S, et al. Prefrontal cortical thickness in first-episode psychosis: a magnetic resonance imaging study. Biol Psychiatry 2004, 55: 131–140.CrossRefPubMedPubMedCentral
23.
go back to reference Rais M, Cahn W, Schnack HG, Hulshoff Pol HE, Kahn RS, van Haren NE. Brain volume reductions in medication-naive patients with schizophrenia in relation to intelligence quotient. Psychol Med 2012, 42: 1847–1856.CrossRefPubMed Rais M, Cahn W, Schnack HG, Hulshoff Pol HE, Kahn RS, van Haren NE. Brain volume reductions in medication-naive patients with schizophrenia in relation to intelligence quotient. Psychol Med 2012, 42: 1847–1856.CrossRefPubMed
24.
go back to reference Lieberman JA. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry 1999, 46: 729–739.CrossRefPubMed Lieberman JA. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry 1999, 46: 729–739.CrossRefPubMed
25.
go back to reference Meyer-Lindenberg A. Neuroimaging and the question of neurodegeneration in schizophrenia. Prog Neurobiol 2011, 95: 514–516.CrossRefPubMed Meyer-Lindenberg A. Neuroimaging and the question of neurodegeneration in schizophrenia. Prog Neurobiol 2011, 95: 514–516.CrossRefPubMed
26.
go back to reference Snitz BE, MacDonald A 3rd, Cohen JD, Cho RY, Becker T, Carter CS. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment. Am J Psychiatry 2005, 162: 2322–2329.CrossRefPubMed Snitz BE, MacDonald A 3rd, Cohen JD, Cho RY, Becker T, Carter CS. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment. Am J Psychiatry 2005, 162: 2322–2329.CrossRefPubMed
27.
go back to reference Gur RE, Maany V, Mozley PD, Swanson C, Bilker W, Gur RC. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am J Psychiatry 1998, 155: 1711–1717.CrossRefPubMed Gur RE, Maany V, Mozley PD, Swanson C, Bilker W, Gur RC. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am J Psychiatry 1998, 155: 1711–1717.CrossRefPubMed
28.
go back to reference Ebdrup BH, Skimminge A, Rasmussen H, Aggernaes B, Oranje B, Lublin H, et al. Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms. Int J Neuropsychopharmacol 2011, 14: 69–82.CrossRefPubMed Ebdrup BH, Skimminge A, Rasmussen H, Aggernaes B, Oranje B, Lublin H, et al. Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms. Int J Neuropsychopharmacol 2011, 14: 69–82.CrossRefPubMed
29.
go back to reference Tost H, Braus DF, Hakimi S, Ruf M, Vollmert C, Hohn F, et al. Acute D2 receptor blockade induces rapid, reversible remodelling in human cortical-striatal circuits. Nat Neurosci 2010, 13: 920–922.CrossRefPubMed Tost H, Braus DF, Hakimi S, Ruf M, Vollmert C, Hohn F, et al. Acute D2 receptor blockade induces rapid, reversible remodelling in human cortical-striatal circuits. Nat Neurosci 2010, 13: 920–922.CrossRefPubMed
30.
go back to reference Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry 2011, 68: 128–137.CrossRefPubMedPubMedCentral Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry 2011, 68: 128–137.CrossRefPubMedPubMedCentral
31.
go back to reference Lewis DA. Antipsychotic medications and brain volume: do we have cause for concern? Arch Gen Psychiatry 2011, 68: 126–127.CrossRefPubMed Lewis DA. Antipsychotic medications and brain volume: do we have cause for concern? Arch Gen Psychiatry 2011, 68: 126–127.CrossRefPubMed
32.
go back to reference Kuperberg GR, Broome MR, McGuire PK, David AS, Eddy M, Ozawa F, et al. Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry 2003, 60: 878–888.CrossRefPubMed Kuperberg GR, Broome MR, McGuire PK, David AS, Eddy M, Ozawa F, et al. Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry 2003, 60: 878–888.CrossRefPubMed
33.
go back to reference Nesvag R, Lawyer G, Varnas K, Fjell AM, Walhovd KB, Frigessi A, et al. Regional thinning of the cerebral cortex in schizophrenia: effects of diagnosis, age and antipsychotic medication. Schizophr Res 2008, 98: 16–28.CrossRefPubMed Nesvag R, Lawyer G, Varnas K, Fjell AM, Walhovd KB, Frigessi A, et al. Regional thinning of the cerebral cortex in schizophrenia: effects of diagnosis, age and antipsychotic medication. Schizophr Res 2008, 98: 16–28.CrossRefPubMed
34.
go back to reference Kubota M, Miyata J, Yoshida H, Hirao K, Fujiwara H, Kawada R, et al. Age-related cortical thinning in schizophrenia. Schizophr Res 2011, 125: 21–29.CrossRefPubMed Kubota M, Miyata J, Yoshida H, Hirao K, Fujiwara H, Kawada R, et al. Age-related cortical thinning in schizophrenia. Schizophr Res 2011, 125: 21–29.CrossRefPubMed
35.
go back to reference Jessen K, Rostrup E, Mandl RCW, Nielsen MO, Bak N, Fagerlund B, et al. Cortical structures and their clinical correlates in antipsychotic-naive schizophrenia patients before and after 6 weeks of dopamine D2/3 receptor antagonist treatment. Psychol Med 2018: 1–10. Jessen K, Rostrup E, Mandl RCW, Nielsen MO, Bak N, Fagerlund B, et al. Cortical structures and their clinical correlates in antipsychotic-naive schizophrenia patients before and after 6 weeks of dopamine D2/3 receptor antagonist treatment. Psychol Med 2018: 1–10.
36.
go back to reference Leung M, Cheung C, Yu K, Yip B, Sham P, Li Q, et al. Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting. Schizophr Bull 2011, 37: 199–211.CrossRefPubMed Leung M, Cheung C, Yu K, Yip B, Sham P, Li Q, et al. Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting. Schizophr Bull 2011, 37: 199–211.CrossRefPubMed
37.
go back to reference First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I & Axis II Disorders (Version 2.0). New York: Biometrics Research, New York State Psychiatric Institute, 1995. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I & Axis II Disorders (Version 2.0). New York: Biometrics Research, New York State Psychiatric Institute, 1995.
38.
go back to reference Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13: 261–276.CrossRefPubMed Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13: 261–276.CrossRefPubMed
39.
go back to reference Morosini PL, Magliano L, Brambilla L, Ugolini S, Pioli R. Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scand 2000, 101: 323–329.PubMed Morosini PL, Magliano L, Brambilla L, Ugolini S, Pioli R. Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scand 2000, 101: 323–329.PubMed
40.
go back to reference Annett M. A classification of hand preference by association analysis. Br J Psychol 1970, 61: 303–321.CrossRefPubMed Annett M. A classification of hand preference by association analysis. Br J Psychol 1970, 61: 303–321.CrossRefPubMed
44.
go back to reference Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 1999, 9: 179–194.PubMed Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 1999, 9: 179–194.PubMed
45.
go back to reference Fischl B, Sereno MI, Dale AM. Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage 1999, 9: 195–207.CrossRefPubMed Fischl B, Sereno MI, Dale AM. Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage 1999, 9: 195–207.CrossRefPubMed
46.
go back to reference Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A 2000, 97: 11050–11055.CrossRefPubMedPubMedCentral Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A 2000, 97: 11050–11055.CrossRefPubMedPubMedCentral
47.
go back to reference Bachmann S, Bottmer C, Pantel J, Schroder J, Amann M, Essig M, et al. MRI-morphometric changes in first-episode schizophrenic patients at 14 months follow-up. Schizophr Res 2004, 67: 301–303.CrossRefPubMed Bachmann S, Bottmer C, Pantel J, Schroder J, Amann M, Essig M, et al. MRI-morphometric changes in first-episode schizophrenic patients at 14 months follow-up. Schizophr Res 2004, 67: 301–303.CrossRefPubMed
48.
go back to reference Zhang W, Deng W, Yao L, Xiao Y, Li F, Liu J, et al. Brain structural abnormalities in a group of never-medicated patients with long-term schizophrenia. Am J Psychiatry 2015, 172: 995–1003.CrossRefPubMed Zhang W, Deng W, Yao L, Xiao Y, Li F, Liu J, et al. Brain structural abnormalities in a group of never-medicated patients with long-term schizophrenia. Am J Psychiatry 2015, 172: 995–1003.CrossRefPubMed
49.
go back to reference Godwin D, Alpert KI, Wang L, Mamah D. Regional cortical thinning in young adults with schizophrenia but not psychotic or non-psychotic bipolar I disorder. Int J Bipolar Disord 2018, 6: 16.CrossRefPubMedPubMedCentral Godwin D, Alpert KI, Wang L, Mamah D. Regional cortical thinning in young adults with schizophrenia but not psychotic or non-psychotic bipolar I disorder. Int J Bipolar Disord 2018, 6: 16.CrossRefPubMedPubMedCentral
50.
go back to reference Kong L, Herold CJ, Zollner F, Salat DH, Lasser MM, Schmid LA, et al. Comparison of grey matter volume and thickness for analysing cortical changes in chronic schizophrenia: a matter of surface area, grey/white matter intensity contrast, and curvature. Psychiatry Res 2015, 231: 176–183.CrossRefPubMed Kong L, Herold CJ, Zollner F, Salat DH, Lasser MM, Schmid LA, et al. Comparison of grey matter volume and thickness for analysing cortical changes in chronic schizophrenia: a matter of surface area, grey/white matter intensity contrast, and curvature. Psychiatry Res 2015, 231: 176–183.CrossRefPubMed
51.
52.
go back to reference Takahashi T, Wood SJ, Yung AR, Phillips LJ, Soulsby B, McGorry PD, et al. Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosis. Schizophr Res 2009, 111: 94–102.CrossRefPubMed Takahashi T, Wood SJ, Yung AR, Phillips LJ, Soulsby B, McGorry PD, et al. Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosis. Schizophr Res 2009, 111: 94–102.CrossRefPubMed
53.
go back to reference Fornito A, Yung AR, Wood SJ, Phillips LJ, Nelson B, Cotton S, et al. Anatomic abnormalities of the anterior cingulate cortex before psychosis onset: an MRI study of ultra-high-risk individuals. Biol Psychiatry 2008, 64: 758–765.CrossRefPubMed Fornito A, Yung AR, Wood SJ, Phillips LJ, Nelson B, Cotton S, et al. Anatomic abnormalities of the anterior cingulate cortex before psychosis onset: an MRI study of ultra-high-risk individuals. Biol Psychiatry 2008, 64: 758–765.CrossRefPubMed
54.
go back to reference Van Haren NE, Cahn W, Hulshoff Pol HE, Kahn RS. Confounders of excessive brain volume loss in schizophrenia. Neurosci Biobehav Rev 2013, 37: 2418–2423.CrossRefPubMed Van Haren NE, Cahn W, Hulshoff Pol HE, Kahn RS. Confounders of excessive brain volume loss in schizophrenia. Neurosci Biobehav Rev 2013, 37: 2418–2423.CrossRefPubMed
55.
go back to reference Ebdrup BH, Norbak H, Borgwardt S, Glenthoj B. Volumetric changes in the basal ganglia after antipsychotic monotherapy: a systematic review. Curr Med Chem 2013, 20: 438–447.PubMedPubMedCentral Ebdrup BH, Norbak H, Borgwardt S, Glenthoj B. Volumetric changes in the basal ganglia after antipsychotic monotherapy: a systematic review. Curr Med Chem 2013, 20: 438–447.PubMedPubMedCentral
56.
go back to reference Hulshoff Pol HE, Schnack HG, Bertens MG, van Haren NE, van der Tweel I, Staal WG, et al. Volume changes in gray matter in patients with schizophrenia. Am J Psychiatry 2002, 159: 244–250.CrossRefPubMed Hulshoff Pol HE, Schnack HG, Bertens MG, van Haren NE, van der Tweel I, Staal WG, et al. Volume changes in gray matter in patients with schizophrenia. Am J Psychiatry 2002, 159: 244–250.CrossRefPubMed
57.
go back to reference van Haren NE, Hulshoff Pol HE, Schnack HG, Cahn W, Brans R, Carati I, et al. Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol Psychiatry 2008, 63: 106–113.CrossRefPubMed van Haren NE, Hulshoff Pol HE, Schnack HG, Cahn W, Brans R, Carati I, et al. Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol Psychiatry 2008, 63: 106–113.CrossRefPubMed
58.
go back to reference Hu ML, Zong XF, Mann JJ, Zheng JJ, Liao YH, Li ZC, et al. A review of the functional and anatomical default mode network in schizophrenia. Neurosci Bull 2017, 33: 73–84.CrossRefPubMed Hu ML, Zong XF, Mann JJ, Zheng JJ, Liao YH, Li ZC, et al. A review of the functional and anatomical default mode network in schizophrenia. Neurosci Bull 2017, 33: 73–84.CrossRefPubMed
59.
go back to reference Lieberman JA. Pathophysiologic mechanisms in the pathogenesis and clinical course of schizophrenia. J Clin Psychiatry 1999, 60: 9–12.CrossRefPubMed Lieberman JA. Pathophysiologic mechanisms in the pathogenesis and clinical course of schizophrenia. J Clin Psychiatry 1999, 60: 9–12.CrossRefPubMed
60.
go back to reference Lieberman JA, Sheitman BB, Kinon BJ. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology 1997, 17: 205–229.CrossRefPubMed Lieberman JA, Sheitman BB, Kinon BJ. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology 1997, 17: 205–229.CrossRefPubMed
61.
go back to reference Waddington JL, Scully PJ, Youssef HA. Developmental trajectory and disease progression in schizophrenia: the conundrum, and insights from a 12-year prospective study in the Monaghan 101. Schizophr Res 1997, 23: 107–118.CrossRefPubMed Waddington JL, Scully PJ, Youssef HA. Developmental trajectory and disease progression in schizophrenia: the conundrum, and insights from a 12-year prospective study in the Monaghan 101. Schizophr Res 1997, 23: 107–118.CrossRefPubMed
62.
go back to reference Woods BT. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am J Psychiatry 1998, 155: 1661–1670.CrossRefPubMed Woods BT. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am J Psychiatry 1998, 155: 1661–1670.CrossRefPubMed
63.
go back to reference Keshavan MS. Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. J Psychiatr Res 1999, 33: 513–521.CrossRefPubMed Keshavan MS. Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. J Psychiatr Res 1999, 33: 513–521.CrossRefPubMed
64.
go back to reference Keshavan MS, Hogarty GE. Brain maturational processes and delayed onset in schizophrenia. Dev Psychopathol 1999, 11: 525–543.CrossRefPubMed Keshavan MS, Hogarty GE. Brain maturational processes and delayed onset in schizophrenia. Dev Psychopathol 1999, 11: 525–543.CrossRefPubMed
65.
go back to reference Shaw P, Greenstein D, Lerch J, Clasen L, Lenroot R, Gogtay N, et al. Intellectual ability and cortical development in children and adolescents. Nature 2006, 440: 676–679.CrossRefPubMed Shaw P, Greenstein D, Lerch J, Clasen L, Lenroot R, Gogtay N, et al. Intellectual ability and cortical development in children and adolescents. Nature 2006, 440: 676–679.CrossRefPubMed
66.
go back to reference Lewis DA, Pierri JN, Volk DW, Melchitzky DS, Woo TU. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia. Biol Psychiatry 1999, 46: 616–626.CrossRefPubMed Lewis DA, Pierri JN, Volk DW, Melchitzky DS, Woo TU. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia. Biol Psychiatry 1999, 46: 616–626.CrossRefPubMed
67.
go back to reference Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000, 57: 65–73.CrossRefPubMed Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000, 57: 65–73.CrossRefPubMed
68.
go back to reference Selemon LD, Goldman-Rakic PS. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry 1999, 45: 17–25.CrossRefPubMed Selemon LD, Goldman-Rakic PS. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry 1999, 45: 17–25.CrossRefPubMed
69.
go back to reference Bubenikova-Valesova V, Horacek J, Vrajova M, Hoschl C. Models of schizophrenia in humans and animals based on inhibition of NMDA receptors. Neurosci Biobehav Rev 2008, 32: 1014–1023.CrossRefPubMed Bubenikova-Valesova V, Horacek J, Vrajova M, Hoschl C. Models of schizophrenia in humans and animals based on inhibition of NMDA receptors. Neurosci Biobehav Rev 2008, 32: 1014–1023.CrossRefPubMed
70.
go back to reference Beninger RJ, Jhamandas A, Aujla H, Xue L, Dagnone RV, Boegman RJ, et al. Neonatal exposure to the glutamate receptor antagonist MK-801: effects on locomotor activity and pre-pulse inhibition before and after sexual maturity in rats. Neurotox Res 2002, 4: 477–488.CrossRefPubMed Beninger RJ, Jhamandas A, Aujla H, Xue L, Dagnone RV, Boegman RJ, et al. Neonatal exposure to the glutamate receptor antagonist MK-801: effects on locomotor activity and pre-pulse inhibition before and after sexual maturity in rats. Neurotox Res 2002, 4: 477–488.CrossRefPubMed
71.
go back to reference Shaw P, Kabani NJ, Lerch JP, Eckstrand K, Lenroot R, Gogtay N, et al. Neurodevelopmental trajectories of the human cerebral cortex. J Neurosci 2008, 28: 3586–3594.CrossRefPubMedPubMedCentral Shaw P, Kabani NJ, Lerch JP, Eckstrand K, Lenroot R, Gogtay N, et al. Neurodevelopmental trajectories of the human cerebral cortex. J Neurosci 2008, 28: 3586–3594.CrossRefPubMedPubMedCentral
72.
go back to reference Dosenbach NU, Nardos B, Cohen AL, Fair DA, Power JD, Church JA, et al. Prediction of individual brain maturity using fMRI. Science 2010, 329: 1358–1361.CrossRefPubMedPubMedCentral Dosenbach NU, Nardos B, Cohen AL, Fair DA, Power JD, Church JA, et al. Prediction of individual brain maturity using fMRI. Science 2010, 329: 1358–1361.CrossRefPubMedPubMedCentral
73.
go back to reference Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS, et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 2002, 288: 1740–1748.CrossRefPubMed Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS, et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 2002, 288: 1740–1748.CrossRefPubMed
Metadata
Title
Age-Related Reduction in Cortical Thickness in First-Episode Treatment-Naïve Patients with Schizophrenia
Authors
Yin Lin
Mingli Li
Yi Zhou
Wei Deng
Xiaohong Ma
Qiang Wang
Wanjun Guo
Yinfei Li
Lijun Jiang
Xun Hu
Nanyin Zhang
Tao Li
Publication date
01-08-2019
Publisher
Springer Singapore
Keyword
Schizophrenia
Published in
Neuroscience Bulletin / Issue 4/2019
Print ISSN: 1673-7067
Electronic ISSN: 1995-8218
DOI
https://doi.org/10.1007/s12264-019-00348-x

Other articles of this Issue 4/2019

Neuroscience Bulletin 4/2019 Go to the issue